Cargando…
De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
Inflammatory bowel disease is a chronic disease of unknown origin that requires long-term treatment. The optical duration of maintenance treatment once remission has been achieved remains unclear. When discussing a de-escalation strategy, not only the likelihood of relapse but also, the outcome of r...
Autores principales: | Miyatani, Yusuke, Kobayashi, Taku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018304/ https://www.ncbi.nlm.nih.gov/pubmed/36375794 http://dx.doi.org/10.5009/gnl220070 |
Ejemplares similares
-
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023) -
De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
por: Thomas, Pepijn W. A., et al.
Publicado: (2022) -
The Mental Health State of Quiescent Inflammatory Bowel Disease Patients
por: Park, Sung Chul, et al.
Publicado: (2016) -
Reducing Health Anxiety in Patients With Inflammatory Bowel Disease Using Video Testimonials: Pilot Assessment of a Video Intervention
por: Shor, Joel, et al.
Publicado: (2023) -
Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease
por: Darlington, Kimberly, et al.
Publicado: (2023)